Table 3.

Quotes from interviews illustrating function 4 – Market Formation.

Quote number (#)	Quote and interviewee
5	“Europe is currently centrally purchasing these vaccines, but for how long? When will the pandemic end and will a normal, healthy market be re-established? Because Europe is buying billions of vaccines from a few suppliers. (…) Eventually we will be in a totally different, endemic situation with annual vaccinations. But the market is already saturated for the upcoming years. This means that other vaccine developers will not invest in developing new vaccines, because of this unequal competition that is now being established. This will eventually lead to less vaccine innovation.” – Respondent #4 – Pharmaceutical Company
6	“We have failed to impose strict requirements to the de-risking of vaccine development. (…) We are already publicly funding the fundamental research, and now also the late-stage development while the pharmaceuticals are taking up all the revenue. This seems strange to me.” – Respondent #5 – Governmental Funding Agency